USPTO serial 85072016
SINUGENIX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- YOUNG, CARRIE SKYE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SINUGENIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Minneapolis, MN
Minneapolis, MN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sherri L Rohlf
Sherri L Rohlf SIEGEL BRILLSUITE 1300100 WASHINGTON AVE. SMINNEAPOLIS, MN 55401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Allergy medications, Allergy eye drops, Allergy relief medications, namely, allergy prevention spray, allergy protective screens, allergy antigens; Antifungal creams for medical use; Antibiotics, antibiotic creams and ointments, antibiotic ophthalmological ointments and solutions, anti-inflammatory decongestants, antihistamine eye drops, moisturizing eye drops, antihistamine nasal sprays, antihistamines; Aromatherapy oils, other than essential oils for treating nasal congestion, fatigue and decreased immunity; Preparations for treatment of asthma; Medical cleansers for skin and wounds; Medical creams for skin care; Decongestants; Cough treatment preparations; Cough suppressants; Injectable epinephrine (EPI) pens and racemic epinephrine for inhalation therapy (nebulization); Nutritionally fortified water, namely, electrically charged water; Medicated hair care preparations; Herbs for medicinal purposes; Natural herbal supplements used in ayurvedic medicines; Homeopathic supplements; Diagnostic test patch for application to the skin for determining allergies; leukotriene inhibitors, namely, pharmaceutical preparations that blunt the inflammatory allergic and asthma inducing response; Moisturizing nasal sprays, moisturizing saline gels solutions for medical purposes; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Pharmaceutical preparations that reduce the viscosity of respiratory mucus; Nasal anticholinergic sprays, nasal decongestants, nasal rinse, nasal steroid spray; Nutraceuticals for use as a dietary supplement; Medications that reduce the release of acid to treat reflux and ulcers; H-2 histamine blockers, namely, medication that reduces the release of histamine; Pharmaceutical preparations for the treatment of dermatitis, urticaria, psoriasis, angioedema, bacterial, viral, fugal and yeast skin infections; Anti-viral medications for skin cleansers; Pain relief medications; cleaning for medical use, namely, sterile solutions for nebulizers; Inhalers filled with racemic epinephrine, long and short acting beta agonsists, inhaled corticosteroids and salmeterol; Customized anti-biotic preparations for use with nebulizers; Vitamins; mineral, dietary and nutritional supplements; Antibacterial, antiviral and anti-inflammatory pharmaceuticals engineered with silver particles and NANO technology; Pharmaceutical preparations in the form of gels and rinses for use as custom nasal prescription formulations and novel bacterial applications consisting of blends of antibiotics, anti-fungal agents and steroid combinations | ACTIVE | — |
| 010 | Respiratory masks for medical purposes; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems for custom nasal prescription formulations and novel bacterial applications consisting of blends of antibiotics, anti-fungal agents and steroid combinations which are available in various topical delivery systems including gels, rinses and nebulization devices of various sizes; Medical apparatus and units for dosage measuring and monitoring, namely, drug delivery devices and systems for use in measuring charged particles (activated water), nitric oxide gas, UV light and laser ionization delivery; External nasal dilators and internal nasal splints "springs" and internal nasal dilators; Nebulizers for respiration therapy; nasal irrigation vessel and mechanical installation device; Inhalers for medical purpose; Replacement parts for nebulizers, namely, mouthpieces, masks, chinstraps, filters and tubing; Spirometer/peak flow meters, namely, devices used to measure breathing capacity in asthmatics and chronic obstructive pulmonary disease patients; Instruments and apparatus provided empty for the inhalation of pharmaceuticals designed to deliver cleansing via balanced sterile saline solution into the respiratory and medications to improve ventilation by their various anti-inflammatory, anti-bacterial, anti-fungal, mucolytic and cronchi-dilatory effecters | ACTIVE | — |
| 011 | Air filtration installations; Air filtering installations, namely, gas phase and hybrid filters; HEPA filters for household use; HEPA vacuum cleaners for household purposes; Humidifiers; UV lamps | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SinuGenix, LLC
- Other trademarks owned by SinuGenix, LLC
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 011
- Similar marks named SINUGENIX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 7, 2013 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 7, 2013 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 5, 2012 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 10, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 10, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 21, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 5, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 2, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 20, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 20, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 20, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 20, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 31, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 31, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2012 | PGRR | PETITION GRANTED - RESPONSE RECEIVED | — |
| Jan 12, 2012 | APET | ASSIGNED TO PETITION STAFF | — |
| Dec 20, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 20, 2011 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 16, 2011 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 15, 2011 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 17, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 17, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 17, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 22, 2011 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2011 | ALIE | ASSIGNED TO LIE | — |
| Apr 13, 2011 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 14, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 30, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 29, 2010 | NWAP | NEW APPLICATION ENTERED | — |